Dr Agarwals Eye Hospital Ltd.
| BSE: 526783 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE934C01018 |
| BSE 15:19 | 04 Jul | 680.00 |
24.90 (3.80%) |
OPEN
658.00 |
HIGH
680.00 |
LOW
635.20 |
| NSE 05:30 | 01 Jan | Dr Agarwals Eye Hospital Ltd |
| OPEN | 658.00 |
| PREVIOUS CLOSE | 655.10 |
| VOLUME | 319 |
| 52-Week high | 925.00 |
| 52-Week low | 380.70 |
| P/E | 13.26 |
| Mkt Cap.(Rs cr) | 320 |
| Buy Price | 631.00 |
| Buy Qty | 2.00 |
| Sell Price | 680.00 |
| Sell Qty | 44.00 |
Dr Agarwals Eye Hospital Ltd. (DRAGARWALSEYE) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 830.25 | 0.43 | 966.90 | 664.10 | 199201.88 |
| Divi's Lab. | 3646.20 | 0.31 | 5425.00 | 3365.10 | 96788.38 |
| Cipla | 930.95 | -2.02 | 1083.15 | 850.00 | 75118.36 |
| Dr Reddy's Labs | 4340.00 | -1.01 | 5613.65 | 3655.00 | 72234.96 |
| Apollo Hospitals | 3774.20 | 1.05 | 5930.70 | 3365.90 | 54265.45 |
| Torrent Pharma. | 2901.85 | -0.45 | 3304.45 | 2485.00 | 49105.11 |
| Gland Pharma | 2594.30 | -2.32 | 4350.00 | 2498.00 | 42728.12 |
| Abbott India | 18941.50 | -0.74 | 23902.30 | 15525.00 | 40250.69 |
| Piramal Enterp. | 1679.55 | 0.55 | 3013.00 | 1561.00 | 40082.46 |
| Biocon | 311.60 | -0.02 | 414.30 | 305.00 | 37410.70 |
| Zydus Lifesci. | 360.30 | -0.50 | 655.00 | 319.40 | 36883.91 |
| Alkem Lab | 3037.40 | 0.57 | 4067.70 | 2835.00 | 36312.12 |
| Max Healthcare | 366.00 | 1.77 | 472.60 | 252.35 | 35488.46 |
| Aurobindo Pharma | 528.90 | 1.22 | 1012.90 | 503.40 | 30988.25 |
| Lupin | 628.20 | -0.06 | 1193.00 | 583.05 | 28557.97 |
| Glaxosmi. Pharma | 1531.00 | 1.84 | 1917.00 | 1433.05 | 25936.67 |
| Laurus Labs | 469.70 | 0.74 | 723.55 | 433.20 | 25239.33 |
| Ipca Labs. | 918.30 | 0.59 | 1383.55 | 831.40 | 23297.27 |
| Syngene Intl. | 557.70 | -0.59 | 699.95 | 508.10 | 22387.75 |
| Pfizer | 4103.05 | -0.24 | 6164.80 | 4056.00 | 18771.45 |
Quick Links for Dr Agarwals Eye Hospital:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
